CSL Hong Kong Aleviate Human Coagulation Factor VIII 250IU/von Willebrand factor 500IU complex, Powder for injection (50 IU/mL FVIII)

국가: 오스트레일리아

언어: 영어

출처: Department of Health (Therapeutic Goods Administration)

유효 성분:

Factor VIII, Quantity: 250 IU; Von willebrand factor, Quantity: 500 IU

제공처:

CSL Behring Australia Pty Ltd

INN (국제 이름):

Factor VIII,Von willebrand factor

약제 형태:

Injection, solution

구성:

Excipient Ingredients: water for injections

관리 경로:

Intravenous

패키지 단위:

Not Required

처방전 유형:

(S1) This Schedule is intentionally blank

치료 징후:

Aleviate is indicated for: ? the treatment of bleeding episodes including surgical bleeding in patients with von Willebrand disease when desmopressin (DDAVP) treatment is ineffective or contraindicated. ? the treatment and prophylaxis of bleeding associated with factor FVIII deficiency due to haemophilia A.

제품 요약:

Visual Identification: Clear, colourless solution; Container Life Time: 3 Years; Container Temperature: Store at 2 to 8 degrees Celsius

승인 상태:

Licence status A

승인 날짜:

2004-06-17